NASDAQ:NRXS NeurAxis (NRXS) Stock Price, News & Analysis $5.18 -0.25 (-4.52%) As of 10:05 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About NeurAxis Stock (NASDAQ:NRXS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NeurAxis alerts:Sign Up Key Stats Today's Range$5.11▼$5.4250-Day Range$5.42▼$7.9252-Week Range$2.21▼$9.33Volume75,431 shsAverage Volume135,823 shsMarket Capitalization$55.13 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingModerate Buy Company Overview NeurAxis, Inc. is a medical technology company focused on developing neuromodulation therapies for chronic and functional pain conditions. Its approach uses percutaneous electrical nerve field stimulation (PENFS), which delivers mild electrical impulses through nerves associated with the brain-gut pathway. The company’s lead product, IB-Stim, is a wearable, minimally invasive device cleared by the U.S. Food and Drug Administration for use as an adjunctive treatment for functional abdominal pain associated with irritable bowel syndrome in patients ages 11 to 18 who have not responded to conventional therapy. Treatment is delivered over a four-week period. NeurAxis markets its therapies in the United States and continues to develop neuromodulation treatments for gastrointestinal and related conditions.AI Generated. May Contain Errors. Read More NeurAxis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks55th Percentile Overall ScoreNRXS MarketRank™: 2.747843397475 of 5 starsNeurAxis scored higher than 55% of companies evaluated by MarketBeat, and ranked 463rd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingModerate Buy Consensus RatingNeurAxis has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.Upside PotentialNeurAxis has a consensus price target of $13.00, representing about 150.5% upside from its current price of $5.19.Amount of Analyst CoverageNeurAxis has only been the subject of 1 research reports in the past 90 days.Read more about NeurAxis' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NeurAxis is -2.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeurAxis is -2.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for NRXS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeurAxis does not currently pay a dividend.Dividend GrowthNeurAxis does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.16 News SentimentNeurAxis has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for NeurAxis this week, compared to 1 article on an average week. Company Ownership4.4 / 5Insider TradingAcquiring Shares Cluster Insider Buying3 insiders have purchased shares of NeurAxis in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $12,260.00 in company stock, which represents 0.0222% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, NeurAxis insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,260.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders21.10% of the stock of NeurAxis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions11.77% of the stock of NeurAxis is held by institutions.Read more about NeurAxis' insider trading history. Receive NRXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRXS Stock News HeadlinesNeurAxis Earnings Call Highlights Growth and Cash Challenges1 hour ago | theglobeandmail.comNeurAxis' Q3 Loss Widens To $6 Mln Despite 150% Revenue Growth; Gains FDA Clearance For IB-StimNovember 10, 2026 | rttnews.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 16 at 1:00 AM | Porter & Company (Ad)NeurAxis (NRXS) Q3 2026 Earnings Call TranscriptNovember 9, 2026 | finance.yahoo.comNeurAxis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 9, 2026 | marketscreener.comMNeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue GrowthNovember 9, 2026 | globenewswire.comNeurAxis (NRXS) Projected to Announce Quarterly Earnings on MondayNovember 8, 2026 | americanbankingnews.comEarnings To Watch: Neuraxis Inc (NRXS) Q3 2026 -- GF Value Sees 48% DownsideNovember 6, 2026 | finance.yahoo.comSee More Headlines NRXS Stock Analysis - Frequently Asked Questions How have NRXS shares performed this year? NeurAxis' stock was trading at $4.54 at the beginning of the year. Since then, NRXS stock has increased by 14.3% and is now trading at $5.19. How were NeurAxis' earnings last quarter? NeurAxis, Inc. (NASDAQ:NRXS) announced its earnings results on Tuesday, November, 12th. The company reported ($0.25) EPS for the quarter. The firm earned $670 thousand during the quarter. When did NeurAxis IPO? NeurAxis (NRXS) raised $7 million in an initial public offering (IPO) on Wednesday, August 9th 2023. The company issued 1,098,667 shares at a price of $6.00 per share. Who are NeurAxis' major shareholders? NeurAxis' top institutional shareholders include AIGH Capital Management LLC (4.30%), Money Concepts Capital Corp (1.88%), State Street Corp (0.38%) and T3 Companies LLC (0.22%). Insiders that own company stock include Gil Aharon, Brian Allen Carrico, Thomas Joeseph Carrico, Timothy Robert Henrichs and Corp Masimo. View institutional ownership trends. How do I buy shares of NeurAxis? Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NRXS CIK1933567 Webneuraxis.com Phone(812) 689-0791FaxN/AEmployees24Year Founded2011Price Target and Rating Average Price Target for NeurAxis$13.00 High Price Target$13.00 Low Price Target$13.00 Potential Upside/Downside+150.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($1.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.63 million Net Margins-492.76% Pretax Margin-341.35% Return on EquityN/A Return on Assets-641.25% Debt Debt-to-Equity RatioN/A Current Ratio0.24 Quick Ratio0.23 Sales & Book Value Annual Sales$6.53 million Price / Sales8.46 Cash FlowN/A Price / Cash FlowN/A Book Value($0.27) per share Price / Book-19.22Miscellaneous Outstanding Shares10,653,000Free Float6,085,000Market Cap$55.29 million OptionableOptionable Beta1.39 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:NRXS) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsThe U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trad...Patriot Gold Group | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.